Oncolytics Biotech ONCY 深 沪
已收盘 10-31 16:00:00 美东时间
1.19
+0.030
+2.59%
华盛通- 最 高1.19
- 今 开1.17
- 成交量 55.31万股
- 最 低 1.14
- 昨 收 1.16
- 总市值 1.20亿
- 52周最高 1.51
- 市盈率 静 --
- 换手率 0.55%
- 52周最低 0.3258
- 委 比 -53.85%
- 总股本 1.01亿
- 历史最高 6.037
- 量 比 0.53
- 振 幅 4.31%
- 历史最低 0.3258
- 每 手 1
- 风险率 0.28%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Oncolytics Biotech Plans Jurisdiction Shift to Nevada
Oncolytics Biotech ( ($ONCY) ) has shared an update. Oncolytics Biotech Inc. ha...
10-20 21:39
Oncolytics Biotech Plans Move From Canada To U.S. With Proposed Domestication To Nevada
Oncolytics Biotech® Inc. (NASDAQ:ONCY) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing pelareorep, today announced it has filed a registration statement on Form F-4 with the
10-20 21:12
Oncolytics Biotech Highlights Pelareorep’s Potential in Cancer Therapy
Oncolytics Biotech ( ($ONCY) ) has shared an update. On October 10, 2025, Oncol...
10-11 05:47
Oncolytics Biotech® Announces Update for Potential First-Line Pancreatic Cancer Registration Study
SAN DIEGO, Sept. 29, 2025 /PRNewswire/ -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing pelareorep, today announc...
09-29 20:30
Cancer Immunotherapy Surge Drives $258B Market as FDA Accelerates Approvals
Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Sept. 16, 2025 /PRNewswire/ -- USA News Group News Commentary – The FDA's accelerated approval of two oncology treatments in August...
09-17 00:29
Oncolytics Biotech® Provides Update on GOBLET Study Progress and U.S. Site Expansion
SAN DIEGO, Sept. 16, 2025 /PRNewswire/ -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing pelareorep, today announc...
09-16 19:00
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Check-Cap (NASDAQ:CHEK) stock increased by 353.1% to $3.38 during Mond...
09-15 20:10
Breakthrough Therapy Designations Surge as $50B Cancer Drug Partnerships Reshape Market
USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Sept. 8, 2025 /PRNewswire/ -- USA News Group News Commentary – The FDA's unprecedented wave of Break...
09-08 21:30
Oncolytics Biotech Updates Pelareorep Safety Data for Gastrointestinal Tumors
The latest update is out from Oncolytics Biotech ( ($ONCY) ). On September 2, 2...
09-02 21:53
